Dublin, Ireland, October 17, 2013 Inflection Biosciences Ltd, a private company focused on the development of targeted small molecule treatments for cancer, today announced a scheduled poster presentation at the 2013 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference taking place on October 19-23 at the Hynes Convention Centre in Boston, USA. The poster presentation (Abstract #A275) entitled, “Co-targeting PIM and PI3K/mTOR pathways with a single molecule: No